SOM Biotech is a late clinical-stage biopharmaceutical company focused on discovering and developing new impactful treatments for rare diseases of the CNS using an AI-driven platf…
Portfolio
A closer look at the companies associated with this firm. Verified team members can update the portfolio after signing in.
This is the portfolio currently shown on the public firm page.
SOM Biotech is a late clinical-stage biopharmaceutical company focused on discovering and developing new impactful treatments for rare diseases of the CNS using an AI-driven platf…
Neurofenix is a tech-enabled virtual care provider that helps neurological patients achieve their rehabilitation goals at home through personalized, engaging, and evidence-based t…
SeaBeLife is a biotechnology company developing innovative small molecules that simultaneously target two major regulated cell death pathways - necroptosis and ferroptosis - desig…
Hyivy Health is a woman-owned company focused on pelvic health rehabilitation, providing innovative solutions for patients and clinicians. Their mission is to improve the standard…
Endostart is a startup focused on the development and manufacturing of a new generation of medical devices for gastrointestinal endoscopy, utilizing innovative Magnetic Balloon Te…
EpilepsyGTx is a late preclinical-stage biotech developing cutting-edge gene therapies that will transform the management of focal refractory epilepsy (FRE).
Leuko is developing PointCheck™, the first device for non-invasive white blood cell monitoring. This portable device allows for fast and simple assessment of white blood cell leve…
Lys Therapeutics is a biotechnology company developing first-in-class monoclonal antibodies to treat patients suffering from neurodegenerative and neurovascular diseases with high…